HANCOCK® II T510C25 (UDI 00643169594395)Recalls & reported problems
Medtronic, Inc. · VLV T510C25 HKII MIT CINCH US PEEK · Class 3 · Implant
All models of HANCOCK II (43)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 4
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00643169594395), received between Feb 15, 2018 and Jul 5, 2024 — classified as 4 injuries.
The most frequently reported specific device problem is “Inadequacy of Device Shape and/or Size” (1 report).
4 other recalls cover devices cleared under the same FDA submission (P980043); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Appropriate Device Problem Term/Code Not Available1
- Inadequacy of Device Shape and/or Size1
- Insufficient Device Problem Information1
- Patient Device Interaction Problem1
Patient problems
- Bradycardia1
- Heart Block1
- Insufficient Information1
- Obstruction/Occlusion1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryJul 5, 2024Patient Device Interaction Problem; Patient Device Interaction Problem
MEDTRONIC RECEIVED INFORMATION THAT ON THE SAME DAY POST IMPLANT OF THIS 25MM MITRAL BIOPROSTHETIC VALVE AND 32MM TRICUSPID ANNULOPLASTY BAND, A PERMANENT PACEMAKER WAS IMPLANTED. THE REASON FOR THE PERMANENT PACEMAKER WAS REPORTED AS COMPLETE HEART BLOCK (CHB). NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Heart Block
MAUDE report 19678917 ↗InjurySep 23, 2021Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT OF THIS 25MM MITRAL BIOPROSTHETIC VALVE, IT WAS EXPLANTED AND REPLACED WITH A 26MM MITRAL MECHANICAL VALVE. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information
MAUDE report 12519015 ↗InjuryJul 24, 2020Inadequacy of Device Shape and/or Size; Inadequacy of Device Shape and/or Size
MEDTRONIC RECEIVED INFORMATION THAT DURING THE IMPLANT OF THIS 25MM MITRAL BIOPROSTHETIC VALVE, THE STENT POSTS IMPEDED THE LEFT VENTRICULAR OUTFLOW TRACT (LVOT) CAUSING TURBULENT FLOW VISIBLE ON ECHO AFTER COMING OFF BYPASS. THE AORTIC GRADIENT WAS TAKEN TO VALIDATE LVOT OBSTRUCTION AND THE GRADIENT WAS 20MMHG, FROM A BASELINE OF 4MMHG. THE PATIENT WAS PUT BACK ON BYPASS AND THE 25MM VALVE WAS EXPLANTED AND REPLACED WITH A NON-MEDTRONIC MITRAL VALVE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Obstruction/Occlusion
MAUDE report 10320058 ↗InjuryFeb 15, 2018Appropriate Device Problem Term/Code Not Available; Appropriate Device Problem Term/Code Not Available
MEDTRONIC RECEIVED INFORMATION FROM THE PATIENT'S DAUGHTER THAT 2 DAYS POST IMPLANT OF THIS MITRAL BIOPROSTHETIC VALVE A NON-MEDTRONIC PERMANENT PACEMAKER WAS IMPLANTED. THE REASON FOR PERMANENT PACEMAKER IMPLANT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. NOTE: A NON-MEDTRONIC AORTIC BIOPROSTHETIC VALVE WAS IMPLANTED DURING THE SAME PROCEDURE.
Patient problems: Bradycardia
MAUDE report 7274523 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P980043. One submission often covers many models, so check the product and lot details in each record.
- Z-1882-2019 · May 21, 2019 · TerminatedHancock II T510 Bioprosthesis, Mitral, REF T505U227 - Product Usage: Replacement of malfunctioning native or prosthetic aortic and/or mitral valves.
- Z-1884-2019 · May 21, 2019 · TerminatedHancock II T510 Bioprosthesis, Mitral, REF T510C27 - Product Usage: Replacement of malfunctioning native or prosthetic aortic and/or mitral valves.
- Z-1883-2019 · May 21, 2019 · TerminatedHancock II T510 Bioprosthesis, Mitral, REF T510C27 - Product Usage: Replacement of malfunctioning native or prosthetic aortic and/or mitral valves.
- Z-1226-2009 · Jan 26, 2009 · TerminatedHancock II Bioprostheses with Cinch, Heart Valve, Model # T505 & T510; Catalog #s T505C2501, T505C2101, T505U25ID , T505C2301, T505C2301, T505C2501, T505C2101, T510C29ID, T510C25ID
Other replacement Heart-valve devices
- CARPENTIER-EDWARDS PERIMOUNT MAGNA EASE PERICARDIAL BIOPROSTHESIS - AORTIC 3300TFXEdwards Lifesciences LLC · replacement Heart-valve4 deaths671 reports
- CARPENTIER-EDWARDS PERIMOUNT MAGNA EASE PERICARDIAL BIOPROSTHESIS - AORTIC 3300TFXEdwards Lifesciences LLC · replacement Heart-valve1 death656 reports
- CARPENTIER-EDWARDS PERIMOUNT MAGNA EASE PERICARDIAL BIOPROSTHESIS - AORTIC 3300TFXEdwards Lifesciences LLC · replacement Heart-valve5 deaths533 reports
- CARPENTIER-EDWARDS PERIMOUNT MAGNA MITRAL EASE PERICARDIAL BIOPROSTHESIS 7300TFXEdwards Lifesciences LLC · replacement Heart-valve1 death425 reports
- CARPENTIER-EDWARDS PERIMOUNT MAGNA MITRAL EASE PERICARDIAL BIOPROSTHESIS 7300TFXEdwards Lifesciences LLC · replacement Heart-valve1 death391 reports
- CARPENTIER-EDWARDS PERIMOUNT MAGNA MITRAL EASE PERICARDIAL BIOPROSTHESIS 7300TFXEdwards Lifesciences LLC · replacement Heart-valve1 death290 reports
- CARPENTIER-EDWARDS PERIMOUNT MAGNA EASE PERICARDIAL BIOPROSTHESIS - AORTIC 3300TFXEdwards Lifesciences LLC · replacement Heart-valve260 reports
- CARPENTIER-EDWARDS PERIMOUNT MAGNA MITRAL EASE PERICARDIAL BIOPROSTHESIS 7300TFXEdwards Lifesciences LLC · replacement Heart-valve2 deaths229 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page